The executive departures come amid investigations into the hospital’s infection control issues. CMS sent Sparrow Carson a Medicare contract termination notice Feb. 6, after a federal investigation revealed the hospital was out of compliance with infection control standards.
The hospital submitted a plan of correction to address the infection issues and prevent the end of Medicare reimbursements. The plan of correction promised “changes with executive leaders and physicians” by Feb. 16, long-term changes in “leadership management” and an analysis of the hospital’s infection prevention program.
Raymond Phillip Allard, MD, a former orthopedic surgeon at Sparrow Carson, is also under investigation by state regulators. Nurse anesthetist Jonnie Vanderhoef, MSN, CRNA, complained Dr. Allard had high infection rates. Sparrow Carson ended a contract with Mr. Vanderhoef in November, shortly after the state confirmed an investigation into Dr. Allard.
Mr. Vanderhoef filed a whistle-blower lawsuit against Sparrow Carson in February, which alleges he informed hospital leadership of his concerns regarding Dr. Allard “on numerous occasions.”
Ms. McQuillan, who began in her role as CNO and COO at Sparrow Carson in February 2015, was among the supervisors and administrators Mr. Vanderhoef said knew about his concerns. Mr. Vanderhoef’s lawsuit also claims Ms. McQuillan was one of several hospital leaders involved in his Nov. 3 firing.
Ms. McQuillan told state investigators the hospital’s administration discussed a surgeon’s surgical site infection rates, “but peer review and surgeon interviews had revealed that Staff I’s patients had multiple risk factors that placed them at higher risk than average for a post operative infection,” according to a CMS report on the hospital’s infection issues that includes an interview with Ms. McQuillan.
A Sparrow Carson spokesperson declined to elaborate to the Lansing State Journal on the circumstances of Ms. McQuillan’s departure.
More articles on healthcare quality:
CMS to offer $30M in grants to develop new quality measures
How OSU Wexner physicians are using 3-D heart models to improve valve replacement surgeries
The Joint Commission names new chief nurse executive: 5 points
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
